American Healthcare REIT, Inc.
For the period ended Sep 30, 2026. Filed Nov 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
PART I — FINANCIAL INFORMATION Item 1. Financial Statements (Unaudited)
| September 30, 2026 | December 31,2025 | |
|---|---|---|
| ASSETS | ||
| Real estate investments, net | $5,949,084 | $4,183,419 |
| Debt investments, net | 240,808 | 92,136 |
| Cash and cash equivalents | 222,767 | 114,836 |
| Restricted cash | 35,905 | 36,917 |
| Accounts and other receivables, net | 228,503 | 204,313 |
| Identified intangible assets, net | 370,206 | 253,236 |
| Goodwill | 234,942 | 234,942 |
| Operating lease right-of-use assets, net | 149,524 | 135,399 |
| Other assets, net | 177,618 | 171,028 |
| Total assets | $7,609,357 | $5,426,226 |
| LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY | ||
| Liabilities: | ||
| Mortgage loans payable, net(1) | $814,957 | $966,925 |
| Lines of credit and term loan, net(1) | 549,927 | 549,761 |
| Accounts payable and accrued liabilities(1) | 372,123 | 317,742 |
| Identified intangible liabilities, net | 1,717 | 2,110 |
| Financing obligations(1) | 19,208 | 33,902 |
| Operating lease liabilities(1) | 135,430 | 135,603 |
| Security deposits, prepaid rent and other liabilities(1) | 66,538 | 59,568 |
| Total liabilities | 1,959,900 | 2,065,611 |
| Commitments and contingencies (Note 10) | ||
| Redeemable noncontrolling interests (Note 11) | 66,810 | — |
| Equity: | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.01 par value per share; 200,000,000 shares authorized; none issued and outstanding | — | — |
| Common stock, $0.01 par value per share; 1,000,000,000 shares authorized; 231,479,253 and 185,911,442 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | 2,311 | 1,852 |
| Additional paid-in capital | 7,164,243 | 4,880,169 |
| Accumulated deficit | (1,628,682) | (1,559,279) |
| Accumulated other comprehensive loss | (2,205) | (2,104) |
| Total stockholders’ equity | 5,535,667 | 3,320,638 |
| Noncontrolling interests | 46,980 | 39,977 |
| Total equity | 5,582,647 | 3,360,615 |
| Total liabilities, redeemable noncontrolling interests and equity | $7,609,357 | $5,426,226 |
(1)
Such liabilities of American Healthcare REIT, Inc. represented liabilities of American Healthcare REIT Holdings, LP or its consolidated subsidiaries as of September 30, 2026 and December 31, 2025. American Healthcare REIT Holdings, LP is a variable interest entity, or VIE, and a consolidated subsidiary of American Healthcare REIT, Inc. The creditors of American Healthcare REIT Holdings, LP or its consolidated subsidiaries do not have recourse against American Healthcare REIT, Inc., except for the 2026 Credit Facility, as defined in Note 8, Lines of Credit and Term Loan, held by American Healthcare REIT Holdings, LP in the amount of $550,000 as of September 30, 2026 and the 2024 Credit Facility, as defined in Note 8, Lines of Credit and Term Loan, held by American Healthcare REIT Holdings, LP in the amount of $550,000 as of December 31, 2025, which were guaranteed by American Healthcare REIT, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Revenues: | ||||
| Resident fees and services | $701,093 | $532,058 | $1,945,379 | $1,530,519 |
| Real estate revenue | 41,056 | 40,879 | 121,794 | 125,524 |
| Total revenues | 742,149 | 572,937 | 2,067,173 | 1,656,043 |
| Expenses: | ||||
| Property operating expenses | 564,735 | 454,530 | 1,601,744 | 1,313,238 |
| Rental expenses | 12,619 | 12,592 | 37,892 | 39,225 |
| General and administrative | 21,582 | 14,108 | 59,078 | 42,206 |
| Transaction, transition and restructuring costs | 5,113 | 50 | 9,870 | 1,808 |
| Depreciation and amortization | 90,869 | 49,181 | 230,056 | 132,236 |
| Total expenses | 694,918 | 530,461 | 1,938,640 | 1,528,713 |
| Other income (expense): | ||||
| Interest expense: | ||||
| Interest expense, net | (17,773) | (20,392) | (55,195) | (65,969) |
| (Loss) gain in fair value of derivative financial instruments | (106) | 166 | 1,778 | (1,213) |
| Gain (loss) on dispositions of real estate investments, net | — | 691 | 5,647 | (2,344) |
| Impairment of real estate investments | — | (3,768) | (2,137) | (38,133) |
| Income (loss) from unconsolidated entities | 49 | 462 | 1,733 | (2,624) |
| Gain on re-measurement of previously held equity interest | — | 14,580 | — | 14,580 |
| Foreign currency (loss) gain | (619) | (977) | (1,363) | 3,181 |
| Other income, net | 3,473 | 2,309 | 7,722 | 5,314 |
| Total net other expense | (14,976) | (6,929) | (41,815) | (87,208) |
| Income before income taxes | 32,255 | 35,547 | 86,718 | 40,122 |
| Income tax (expense) benefit | (740) | 21,092 | (212) | 19,756 |
| Net income | 31,515 | 56,639 | 86,506 | 59,878 |
| Net income attributable to noncontrolling interests | (302) | (712) | (974) | (847) |
| Net income attributable to controlling interest | $31,213 | $55,927 | $85,532 | $59,031 |
| Net income per common share attributable to controlling interest: | ||||
| Basic | $0.14 | $0.33 | $0.43 | $0.36 |
| Diluted | $0.14 | $0.33 | $0.43 | $0.36 |
| Weighted average number of common shares outstanding: | ||||
| Basic | 216,783,990 | 169,010,301 | 199,046,304 | 162,188,510 |
| Diluted | 217,711,583 | 169,802,090 | 199,494,794 | 162,908,219 |
| Net income | $31,515 | $56,639 | $86,506 | $59,878 |
| Other comprehensive income (loss): | ||||
| Foreign currency translation adjustments | 8 | (121) | (101) | 398 |
| Total other comprehensive income (loss) | 8 | (121) | (101) | 398 |
| Comprehensive income | 31,523 | 56,518 | 86,405 | 60,276 |
| Comprehensive income attributable to noncontrolling interests | (302) | (712) | (974) | (847) |
| Comprehensive income attributable to controlling interest | $31,221 | $55,806 | $85,431 | $59,429 |
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.